Takeaways from SWHR's Alzheimer's Disease Working Group highlight needs for improved disease education, research, and care equity for women impacted by Alzheimer’s, both as patients and caregivers.
The Psoriatic Arthritis Toolkit is part of SWHR's program of materials to raise awareness about PsA’s burden on women and support women living with PsA.
The Value of Diagnostics within Women’s Health series in 2022 featured six public forums that sought to highlight the role of screening and diagnostics throughout a woman’s lifespan.
The Infectious Diseases Network meeting in fall 2022 covered the role of education in vaccine uptake and renewed hope for the human papillomavirus (HPV) vaccination rate in the United States.
These are takeaways from SWHR's August 2022 meeting of an interdisciplinary group of policy experts, researchers, clinicians, and patient advocates in women’s autoimmune and immune-mediated diseases.
The diagnostics fact sheet for select cancers prevalent in women aims to help educate women about the important role of screening and diagnostic testing in cancer care.
The Noninvasive Prenatal Screening (NIPS) Resource Guide for Women was created to help pregnant individuals navigate conversations with providers and professionals about their prenatal screening options.
The NASEM report on improving representation in clinical trials outlines the high cost of care and poor patient outcomes that are a consequence of not increasing diversity in research.
SWHR will oversee the Coalition to Advance Maternal Therapeutics (CAMT), a coalition founded in 2014 to increase inclusion of pregnant and lactating populations in clinical research.
During the July 26, 2022, “Taking Heed of Alzheimer’s Disease" briefing, disease stakeholders discussed research and treatment for AD and its disproportionate impact on women.